Abstract:Background: A critical aspect of in silico drug discovery involves the prediction of drug-target affinity (DTA). Conducting wet lab experiments to determine affinity is both expensive and time-consuming, making it necessary to find alternative approaches. In recent years, deep learning has emerged as a promising technique for DTA prediction, leveraging the substantial computational power of modern computers. Methods: We proposed a novel sequence-based approach, named KC-DTA, for predicting drug-target affinity (DTA). In this approach, we converted the target sequence into two distinct matrices, while representing the molecule compound as a graph. The proposed method utilized k-mers analysis and Cartesian product calculation to capture the interactions and evolutionary information among various residues, enabling the creation of the two matrices for target sequence. For molecule, it was represented by constructing a molecular graph where atoms serve as nodes and chemical bonds serve as edges. Subsequently, the obtained target matrices and molecule graph were utilized as inputs for convolutional neural networks (CNNs) and graph neural networks (GNNs) to extract hidden features, which were further used for the prediction of binding affinity. Results: In order to evaluate the effectiveness of the proposed method, we conducted several experiments and made a comprehensive comparison with the state-of-the-art approaches using multiple evaluation metrics. The results of our experiments demonstrated that the KC-DTA method achieves high performance in predicting drug-target affinity (DTA). The findings of this research underscore the significance of the KC-DTA method as a valuable tool in the field of in silico drug discovery, offering promising opportunities for accelerating the drug development process. All the data and code are available for access on https://github.com/syc2017/KCDTA.

Contrastive Meta-Learning for Drug-Target Binding Affinity Prediction

A Case-Based Meta-Learning Algorithm Boosts the Performance of Structure-Based Virtual Screening.

Multimodal contrastive representation learning for drug-target binding affinity prediction

HSGCL-DTA: Hybrid-scale Graph Contrastive Learning Based Drug-Target Binding Affinity Prediction

GraphCL-DTA: a graph contrastive learning with molecular semantics for drug-target binding affinity prediction

Drug-target interaction prediction with collaborative contrastive learning and adaptive self-paced sampling strategy

Predicting drug–target binding affinity with cross-scale graph contrastive learning

ColdDTA: Utilizing data augmentation and attention-based feature fusion for drug-target binding affinity prediction

MGACL: Prediction Drug–Protein Interaction Based on Meta-Graph Association-Aware Contrastive Learning

CCL-DTI: contributing the contrastive loss in drug–target interaction prediction

MRLDTI: A Meta-path-Based Representation Learning Model for Drug-Target Interaction Prediction

Multimodal Protein-Ligand Contrastive Pretraining for Effective and Efficient Drug Discovery

Drug-target Binding Affinity Prediction Model Based on Multi-Scale Diffusion and Interactive Learning

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

Supervised graph co-contrastive learning for drug–target interaction prediction

Predicting Drug-Target Interactions Binding Affinity by Using Dual Updating Multi-task Learning

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

DeepMHADTA: Prediction of Drug-Target Binding Affinity Using Multi-Head Self-Attention and Convolutional Neural Network

A Heterogeneous Cross Contrastive Learning Method for Drug-Target Interaction Prediction

MTAF–DTA: multi-type attention fusion network for drug–target affinity prediction

Binding Affinity Prediction with 3D Machine Learning: Training Data and Challenging External Testing